Navigating Therapies for BCG-Unresponsive NMIBC: Immunotherapies and Chemotherapies
Experts discuss the evolving landscape of chemotherapy and immunotherapy options for patients with non-muscle invasive bladder cancer (NMIBC).
Related Articles
Transmeatal Endoscopic Management of Anterior Urethral Strictures: Thinking Outside the Box – American Urological Association
The buccal graft urethroplasty, first introduced by Kirill Sapezhko in the early 19th century, has led to remarkable improvements in urethral reconstructive surgery. The popularization…
EAU Guidelines on MIBC – DISEASE MANAGEMENT – Uroweb
The EAU Guidelines Panel for Muscle-invasive and Metastatic Bladder Cancer (MIBC) have prepared these guidelines to help urologists assess the evidence-based management of MIBC and…
FDA: Diabetes Device Alerts May Be Missed Due to Smartphone Settings
The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.
Survey data highlights substantial impact of postpartum incontinence
Overall, 85% of respondents indicating that they experienced frequent bladder leaks.
2025 AUA Data Research Program Recipients – American Urological Association
Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative…
Robotic Surgery, Multidisciplinary Care for RCC | GU Oncology Now
Dr. Kaouk explains how a multidisciplinary team should be integrated into the management of RCC.
Maladaptive Cardiovascular Reactivity to Mental Stress Linked to Adverse Outcomes
Risk score derived from cardiovascular reactivity predictive of adverse outcomes beyond traditional cardiovascular risk factors in CAD
Reply: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Susvimo Approval Expanded to Include Diabetic Macular Edema
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.